Table 1.
Subject cohort demographics
| Characteristic | Extremely premature infants without or with mild brain injury | Extremely premature infants with severe brain injury | p value (t test and Fisher’s exact test) |
|---|---|---|---|
| Individuals, number | 38 | 15 | |
| GA at birth, weeks | 25.5 ± 1.2 | 24.8 ± 1.3 | 0.100 |
| Birth weight, grams | 774 ± 137 | 718 ± 156 | 0.213 |
| Birth head circumference, cm | 23.2 ± 1.4 | 22.7 ± 1.6 | 0.234 |
| Birth length, cm | 32.9 ± 2.3 | 32.4 ± 2.0 | 0.520 |
| Female gender, % | 63% | 53% | 0.546 |
| Spontaneous birth, % | 11% | 53% | 0.001 |
| IUGR, % | 8% | 13% | 0.614 |
| pPROM, % | 63% | 33% | 0.068 |
| Received lung maturation, % | 97% | 93% | 0.489 |
| Apgar score at 5 min | 8.4 ± 0.9 | 8.4 ± 1 | 0.874 |
| Apgar score at 10 min | 8.7 ± 0.8 | 8.9 ± 0.2 | 0.468 |
| CSI, % | 32% | 47% | 0.351 |
| Culture-proven EOS, % | 5% | 0% | 1 |
| Clinical LOS, % | 16% | 33% | 0.257 |
| Culture-proven LOS, % | 29% | 20% | 0.731 |
| Hospitalization, days | 91.82 ± 37.32 | 91.53 ± 24.29 | 0.884 |
| NEC, % | 8% | 0% | 1 |
| ROP, % | 47% | 100% | 0.0003 |
| BPD, % | 27% | 20% | 0.733 |
| PDA, % | 37% | 60% | 0.217 |
| Antibiotic intervention, days | 15.89 ± 11.5 | 18.00 ± 13.4 | 0.598 |
| Age at discharge, weeks | 39.2 ± 4.5 | 38.7 ± 2.0 | 0.693 |
| Weight at discharge, grams | 2,929 ± 956 | 2,788 ± 325 | 0.600 |
| Length at discharge, cm | 47.0 ± 5.2 | 46.4 ± 2.6 | 0.699 |
| Head circumference at discharge, cm | 33.0 ± 3.1 | 32.8 ± 2.0 | 0.855 |
| Milk formula fortifier administered shortly before discharge | 77% | 77% | 1 |
IUGR, intrauterine growth restriction; pPROM, preterm premature rupture of membranes; CSI, clinical-suspected inflammation; EOS, early-onset sepsis; LOS, late-onset sepsis; BPD, bronchopulmonary dysplasia; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; PDA, persistent ductus arteriosus. Data are presented as mean ± SD or percentage (%).